Caribou Biosciences Inc.

NASDAQ: CRBU · Real-Time Price · USD
1.97
-0.03 (-1.50%)
At close: Aug 15, 2025, 3:59 PM
1.98
0.51%
After-hours: Aug 15, 2025, 05:38 PM EDT

Caribou Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-149.1M -102.07M -99.42M -66.92M
Depreciation & Amortization
3.93M 3.52M 1.62M 984K
Stock-Based Compensation
16.71M 13.75M 11.72M 3.45M
Other Working Capital
-5.37M -9.94M -2.43M 31.13M
Other Non-Cash Items
-4.6M -1.18M -584K 2.43M
Deferred Income Tax
-10K n/a -95K -1.52M
Change in Working Capital
-5.11M -7.32M -4.2M 29.07M
Operating Cash Flow
-138.2M -93.29M -90.97M -32.52M
Capital Expenditures
-4.88M -11.61M -7.05M -3.12M
Cash Acquisitions
n/a n/a 600K n/a
Purchase of Investments
-304.39M -394.76M -339.06M -173.28M
Sales Maturities Of Investments
397.49M 338.19M 252.87M n/a
Other Investing Acitivies
-1.61M n/a -600K n/a
Investing Cash Flow
86.61M -68.18M -93.25M -176.4M
Debt Repayment
n/a n/a n/a 1.03M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.58M n/a 2.55M
Financial Cash Flow
16.72M 154.3M 2.13M 433.43M
Net Cash Flow
-34.87M -7.18M -182.08M 224.51M
Free Cash Flow
-143.08M -104.9M -98.02M -35.64M